Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

Author： Ketterer N. Coiffier B. Thieblemont C. Ferm C. Brire J. Casasnovas O. Bologna S. Christian B. Connerotte T. Rcher C. Bordessoule D. Fruchart C. Delarue R. Bonnet C. Morschhauser F. Anglaret B. Soussain C. Fabiani B. Tilly H. Haioun C.

Publisher： Oxford University Press

ISSN： 0923-7534

Source： Annals of Oncology, Vol.24, Iss.4, 2013-04, pp. : 1032-1037

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term follow-up of localized, primary gastric diffuse large B-cell lymphoma treated with rituximab and CHOP

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 304-308

Spandidos Publications

Access to resources Recommend Favorite

Prognostic Significance of Survivin and Caspase-3 Immunohistochemical Expression in Patients with Diffuse Large B-cell Lymphoma Treated with Rituximab and CHOP

By Mitrović Zdravko

Pathology & Oncology Research, Vol. 17, Iss. 2, 2011-06 ,pp. : 243-247

Springer Publishing Company

Access to resources Recommend Favorite

Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximab

Oncology Letters, Vol. 4, Iss. 3, 2012-01 ,pp. : 541-545

Spandidos Publications

Access to resources Recommend Favorite

Spontaneous Remission in Localized Diffuse Large B-cell Lymphoma

By Tamás László

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 779-784

Springer Publishing Company

Access to resources Recommend Favorite

Management of Diffuse Large B-Cell Lymphoma in Young Patients

By Pfreundschuh Michael

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 349-357

Adis International

Access to resources Recommend Favorite